JLL has been recognized by global biopharmaceutical company Bristol-Myers Squibb with a Service Delivery Excellence Award announced at the company’s annual Global Suppliers Conference.
JLL selected from more than 2,000 companies for annual award
CHICAGO, Oct. 30, 2017 – JLL has been recognized by global biopharmaceutical company Bristol-Myers Squibb with a Service Delivery Excellence Award announced at the company’s annual Global Suppliers Conference.
Since 2015 JLL has provided integrated facilities management, laboratory support services, occupancy planning and relocation program management across Bristol-Myers Squibb facilities in the United States and Puerto Rico. JLL manages more than 10 million square feet of the company’s real estate, which includes manufacturing, laboratory, R&D and office facilities.
“This recognition is a great honor from Bristol-Myers Squibb, which has very high standards for the quality and performance of its facilities and a highly complex and technical scope of work,” said Roger Humphrey, Executive Managing Director of JLL’s Life Sciences group. “Our team of engineering and operational experts and our health, safety, security and environment staff who manage highly regulated spaces have been fundamental to our success. We have a true partnership with Bristol-Myers Squibb and they value our experience and technical expertise.”
JLL’s team of real estate and facility management experts are dedicated to helping life sciences companies optimize and manage their real estate portfolios. The firm provides an industry-leading full-service platform including integrated facilities management, engineering and operations, energy and sustainability, transaction advisory services, lease administration, project management and comprehensive laboratory services.
